35S标记的WR-2721在小鼠正常组织和恶性组织中的分布1,2 。 - Suppr

Suppr

超能文献

Distribution of 35S-labeled WR-2721 in normal and malignant tissues of the mouse1,2.

作者信息

Utley J F, Marlowe C, Waddell W J

出版信息

Radiat Res. 1976 Nov;68(2):284-91.

PMID:185642

Abstract

摘要

相似文献

Distribution of 35S-labeled WR-2721 in normal and malignant tissues of the mouse1,2.35S标记的WR-2721在小鼠正常组织和恶性组织中的分布1,2 。

Radiat Res. 1976 Nov;68(2):284-91.

Biodistribution of the radioprotective drug 35S-labeled 3-amino-2-hydroxypropyl phosphorothioate (WR77913).放射防护药物35S标记的3-氨基-2-羟丙基硫代磷酸酯（WR77913）的生物分布。

Radiat Res. 1985 Apr;102(1):130-7.

Distribution of WR-2721 in normal and malignant tissues of mice and rats bearing solid tumors: dependence on tumor type, drug dose and species.WR-2721在荷实体瘤小鼠和大鼠的正常组织及恶性组织中的分布：对肿瘤类型、药物剂量和物种的依赖性。

Radiat Res. 1974 Aug;59(2):475-83.

Synthesis, biodistribution, and autoradiography of radiolabeled S-2-(3-methylaminopropylamino)ethylphosphorothioic acid (WR-3689).放射性标记的S-2-(3-甲基氨基丙基氨基)乙硫代磷酸（WR-3689）的合成、生物分布及放射自显影

Radiat Res. 1986 Jun;106(3):366-79.

Comparison of the protective effects of three phosphorothioate radioprotectors in the RIF-1 tumor.三种硫代磷酸酯辐射防护剂对RIF-1肿瘤的保护作用比较。

Radiat Res. 1986 Nov;108(2):167-75.

Pharmacokinetics of WR-1065 in mouse tissue following treatment with WR-2721.

Int J Radiat Oncol Biol Phys. 1984 Sep;10(9):1525-8. doi: 10.1016/0360-3016(84)90495-4.

Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution.WR-2721对正常组织的γ射线和回旋加速器中子辐射防护作用：半数致死剂量研究及35S-WR-2721生物分布

Radiat Res. 1984 Mar;97(3):598-607.

[Studies on the radioprotective effects of YM-08310 (= WR-2721) Part 1: Radioprotective effects of YM-08310 on normal and malignant tissues in mice].[YM-08310（=WR-2721）的辐射防护作用研究第1部分：YM-08310对小鼠正常组织和恶性组织的辐射防护作用]

Nihon Igaku Hoshasen Gakkai Zasshi. 1983 May 25;43(5):700-9.

The role of WR-2721 in radiotherapy and/or chemotherapy.WR-2721在放疗和/或化疗中的作用。

Cancer Clin Trials. 1980 Fall;3(3):211-6.

In vitro metabolism of the phosphorothioate radioprotectors WR-2721 and WR-3689.

Pharmacol Ther. 1988;39(1-3):215-7. doi: 10.1016/0163-7258(88)90064-2.

引用本文的文献

[Effect of amifostine on locally advanced non-small cell lung cancer patients treated with radiotherapy: a meta-analysis of randomized controlled trials].

Zhongguo Fei Ai Za Zhi. 2012 Sep;15(9):539-44. doi: 10.3779/j.issn.1009-3419.2012.09.06.

Evaluation of the fullerene compound DF-1 as a radiation protector.评估富勒烯化合物 DF-1 作为辐射防护剂的效果。

Radiat Oncol. 2010 May 11;5:34. doi: 10.1186/1748-717X-5-34.

A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact.癌症治疗所致唾液腺功能低下和口干的系统评价：管理策略和经济影响。

Support Care Cancer. 2010 Aug;18(8):1061-79. doi: 10.1007/s00520-010-0837-6. Epub 2010 Mar 25.

Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer.氨磷汀对大剂量放射性碘治疗分化型甲状腺癌后的唾液腺是否具有放射防护作用。

Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1778-85. doi: 10.1007/s00259-009-1368-6. Epub 2010 Feb 4.

Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer.氨磷汀用于大剂量放射性碘治疗分化型甲状腺癌时的唾液腺保护

Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD007956. doi: 10.1002/14651858.CD007956.pub2.

Sensitivity of salivary glands to radiation: from animal models to therapies.唾液腺对辐射的敏感性：从动物模型到治疗方法

J Dent Res. 2009 Oct;88(10):894-903. doi: 10.1177/0022034509343143.

A risk-benefit assessment of amifostine in cytoprotection.氨磷汀细胞保护作用的风险效益评估。

Drug Saf. 1999 Nov;21(5):367-87. doi: 10.2165/00002018-199921050-00003.

The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects.含巯基化合物WR-2721和谷胱甘肽作为放射和化学防护剂。综述、使用指征及前景。

Br J Cancer. 1999 May;80(5-6):629-38. doi: 10.1038/sj.bjc.6690404.

Effects of amifostine on cisplatin induced DNA adduct formation and toxicity in malignant glioma and normal tissues in rat.氨磷汀对顺铂诱导大鼠恶性胶质瘤及正常组织中DNA加合物形成和毒性的影响。

J Neurooncol. 1999 Mar;42(1):13-21. doi: 10.1023/a:1006152103476.

Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer.氨磷汀在分化型甲状腺癌高剂量放射性碘治疗中对唾液腺的保护作用。

Strahlenther Onkol. 1999 Feb;175(2):57-61. doi: 10.1007/BF02753843.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验